Senores Pharma shares listed at Rs 593.70 apiece on the BSE, reflecting a premium of 51.84 per cent over the IPO allotment ...

Sun Pharma sells subsidiary in Japan to Zaza Industrial Holdings KK, ceasing operations with turnover less than 0.5%.

India’s revised Schedule M norms for pharmaceutical manufacturing, effective January 1, require compliance with stricter ...

WinTrust Pharmaceuticals Ltd. Top Ayurvedic Medicine Manufacturer in India has earned its reputation as a trusted name in the ...

According to stock market observers, shares of the company are available at a premium of ₹191 in the grey market today ...

TAS-0728 is under clinical development by Taiho Pharmaceutical and currently in Phase II for Endometrial Cancer.

Citius Pharma ( (CTXR) ) has released its Q4 earnings. Here is a breakdown of the information Citius Pharma presented to its investors. Citius Pharmaceuticals, Inc. is a biopharmaceutical company ...

Shares of Senores Pharmaceuticals are scheduled to be listed on the stock exchanges today on Monday, December 30, following a ...

The pharmaceutical industry in 2024 faced a relatively quiet year, with deal volumes similar to 2023 but lower deal values, ...

TAS-1440 is under clinical development by Taiho Pharmaceutical and currently in Phase I for Refractory Acute Myeloid Leukemia.

Provides a curated, searchable list of pharmaceutical products, each with an immutable code. A GraphQL API, a REST API and website are available for interaction with the database.

Domestic brokerage Motilal Oswal has recommended Mankind Pharma, Lupin, Max Healthcare, IPCA Laboratories, and Piramal Pharma ...